- AdventHealth
With a renewed focus on improving integration and strengthening teams to provide an optimal patient experience, two new leaders have taken the reins of the AdventHealth Digestive Health Institute (DHI).
Following direct feedback from patients, AdventHealth aligned digestive services to increase access for patients and provide a better experience as they navigate from colonoscopies to surgery as well as metabolic and weight loss medicine.
To foster a team approach to patient care, six different digestive services will be under the same umbrella and leadership team:
- Colorectal surgery
- Gastroenterology
- Weight loss medicine and bariatric surgery
- Endocrinology and diabetes medicine
- General surgery
- Reconstructive and plastic surgery
Technology helps with scheduling appointments
One of the keys for improving patient access is to leverage technology with a new tool for appointment scheduling, according to Margaret White, who was recently named the vice president of the AdventHealth Digestive Health Institute. Called the GI Access Center, the tool is a centralized command center for all a patient’s gastrointestinal (GI) needs. Calling this one-stop-shop number, patients will schedule their appointments and the GI Access Center will look across all AdventHealth facilities to book the earliest available appointment at their desired location – the goal is to get a patient into the hospital and seen by a provider within 72 hours.
On making it easy...
- Margaret White, vice president of the AdventHealth Digestive Health Institute
A native Floridian, White began her career in health care 25 years ago when she graduated with degrees in occupational therapy and nursing before coming to AdventHealth in 2007. While working at AdventHealth, she received a master’s level executive business degree from the University of Miami.
She is an avid runner and regularly participates in AdventHealth Track Shack events as part of the Track Shack Marathon Fest running/training groups, mainly running half marathons and 5K’s these days.
Integrated services in a more relaxed setting
Another new initiative for the Digestive Health Institute is integrating services for weight loss management and bariatric surgery to provide an improved continuum of care. There are also plans for a medical spa in Orlando where community members and digestive health patients have access to the reconstructive and plastic surgery team post-procedure.
The goal is to offer a variety of options in a less clinical setting that’s outside of highly invasive surgical procedures, according to Lindsay Agema, newly named executive director of the AdventHealth Digestive Health Institute.
On better access...
- Lindsay Agema, executive director of the AdventHealth Digestive Health Institute
Agema has been part of the AdventHealth team for 12 years and joins DHI from the strategic planning team where she helped partner with DHI in the development of multi-year business plans and aspirations.
Outside of work, you will find this recent University of Florida master’s program graduate searching for a travel adventure or creating art. In fact, Agema once donated a piece of her artwork to an AdventHealth campus in West Florida.
About the AdventHealth Digestive Health Institute
U.S. News & World Report recently rankedfour AdventHealth Orlando clinical programs, including diabetes and endocrinology, among the nation’s best. Six specialties ranked as “high performing,” including gastroenterology and GI surgery.
The AdventHealth Digestive Health Institute is also home to the largest interventional endoscopy center in the U.S. and we hold multiple accreditations for our subspecialty programs, bringing world-class care to our community. Specialists work together to deliver comprehensive care to treat a spectrum of conditions— from swallowing disorders to inflammatory bowel disease treatment and everything in between.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...